Main Session
Sep
28
PQA 01 - Radiation and Cancer Physics, Sarcoma and Cutaneous Tumors
2309 - Neoadjuvant Immunotherapy Followed by Response-Adapted Definitive Radiotherapy for Unresectable, Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Dosimetric Analysis of a Phase II Clinical Trial
Presenter(s)
Christopher Barker, MD - Memorial Sloan Kettering Cancer Center, New York, NY